News

GEN14y
BTG Nabs U.S. Marketing Rights to Wellstat’s 5-FU Overdose Antidote Candidate
Wellstat projects making an NDA submission for uridine triacetate in 2013. BTG obtained U.S. marketing and distribution rights to Wellstat Therapeutics’ investigational drug uridine triacetate ...
Yahoo Finance3y
Marketing Worldwide Releases Minosis V.5 Update, Adds BTG to Mineable Coins and Embarks on Campaign to Add Users - Yahoo Finance
Marketing Worldwide Releases Minosis V.5 Update, Adds BTG to Mineable Coins and Embarks on Campaign to Add Users MWWC - Contact Information CHEYENNE, WY, April 20, 2022 (GLOBE NEWSWIRE ...
Business Insider4y
BTG Specialty Pharmaceuticals announces the European Medicines Agency has accepted for review a marketing authorisation application for Voraxaze®
LONDON, Aug. 17, 2020 /PRNewswire/ -- BTG Specialty Pharmaceuticals, a division of Boston Scientific (NYSE:BSX), today announced the European Medicines Agency (EMA) has accepted for review a ...
London South East11y
BTG welcomes marketing approval of MS treatment | Financial News - London South East
(Sharecast News) - Broadcaster BT is set to scrap pay-TV packages for monthly prime content subscriptions, granting the flexibility that other streami ...
Business Wire1y
BTG Positioning and GPR sign a multi-year, $40MM contract to supply advanced positioning technology for automated ports. - Business Wire
BTG Positioning Systems, a leading supplier of absolute positioning measurement systems for container terminals, ... and assist in our marketing efforts. Cookie Policy.
Nasdaq4y
BTG Specialty Pharmaceuticals announces the European Medicines Agency has accepted for review a marketing authorisation application for Voraxaze® - Nasdaq
--BTG Specialty Pharmaceuticals, a division of Boston Scientific, today announced the European Medicines Agency has accepted for review a Marketing Authorisation Application for Voraxaze ®.